Patents by Inventor Brian Shields

Brian Shields has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11771497
    Abstract: Devices for therapeutic nasal neuromodulation and associated systems and methods are disclosed herein. A system for therapeutic neuromodulation in a nasal region configured in accordance with embodiments of the present technology can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.
    Type: Grant
    Filed: April 12, 2019
    Date of Patent: October 3, 2023
    Assignee: National University of Ireland, Galway
    Inventors: David Townley, Brian Shields, Ivan Keogh, Michele Qi Zhan, Conor Farrell
  • Patent number: 11701167
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: July 18, 2023
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 11690672
    Abstract: A device for therapeutic neuromodulation in a nasal region can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.
    Type: Grant
    Filed: April 12, 2019
    Date of Patent: July 4, 2023
    Assignee: National University of Ireland, Galway
    Inventors: David Townley, Brian Shields, Ivan Keogh, Michele Qi Zhan, Conor Farrell
  • Patent number: 11684414
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: June 27, 2023
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 11666378
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: June 6, 2023
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 11576719
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: May 22, 2020
    Date of Patent: February 14, 2023
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 11547473
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: January 10, 2023
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 11547472
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: January 10, 2023
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 11419671
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: August 23, 2022
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Publication number: 20220125504
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Application
    Filed: December 6, 2019
    Publication date: April 28, 2022
    Inventors: David Townley, Brian Shields
  • Publication number: 20210169566
    Abstract: Devices for therapeutic nasal neuromodulation and associated systems and methods are disclosed herein. A system for therapeutic neuromodulation in a nasal region configured in accordance with embodiments of the present technology can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.
    Type: Application
    Filed: December 4, 2019
    Publication date: June 10, 2021
    Applicants: National University of Ireland, Galway, National University of Ireland, Galway
    Inventors: David Townley, Brian Shields, Ivan Keogh, Michele Qi Zhan, Conor Farrell
  • Patent number: 11026746
    Abstract: Devices for therapeutic nasal neuromodulation and associated systems and methods are disclosed herein. A system for therapeutic neuromodulation in a nasal region configured in accordance with embodiments of the present technology can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.
    Type: Grant
    Filed: May 12, 2016
    Date of Patent: June 8, 2021
    Assignee: National University of Ireland, Galway
    Inventors: David Townley, Brian Shields, Ivan Keogh, Michele Qi Zhan, Conor Farrell
  • Patent number: 10806921
    Abstract: Devices, systems, and methods for specializing, monitoring, and/or evaluating therapeutic nasal neuromodulation are disclosed herein. A targeted neuromodulation system configured in accordance with embodiments of the present technology can include, for example, an evaluation/modulation assembly at a distal portion of a shaft and including a plurality of electrodes. The electrodes are configured to emit stimulating energy at frequencies for identifying and locating target neural structures and detect the resultant bioelectric properties of the tissue. The system can also include a console that maps locations of the target neural structures. The evaluation/modulation assembly can then apply therapeutic neuromodulation energy in a highly tailored neuromodulation pattern based on the mapped locations of the target neural structures. Accordingly, the system provides therapeutic neuromodulation to highly specific target structures while avoiding non-target structures to reduce collateral effects.
    Type: Grant
    Filed: November 26, 2019
    Date of Patent: October 20, 2020
    Assignee: National University of Ireland, Galway
    Inventors: David Townley, Brian Shields, Ivan Keogh, Peter Dockery, Ian Stephen O'Brien, Martin O'Halloran, Emily Elizabeth Porter, Marggie Jones
  • Publication number: 20200282207
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Application
    Filed: May 22, 2020
    Publication date: September 10, 2020
    Inventors: David Townley, Brian Shields
  • Publication number: 20200225991
    Abstract: A job that receives as input a data stream is executed. For the job, it is iteratively determined a backlog growth over a first period of time; a backlog volume; and whether to adjust a quantity of processing resources. For each iteration for which the quantity of processing resources allocated to the job are determined to be adjusted, adjusting the quantity of processing resources allocated to the job. For each iteration for which the quantity of processing resources allocated to the job are determined not to be adjusted, maintaining the quantity of processing resources allocated to the job.
    Type: Application
    Filed: February 4, 2020
    Publication date: July 16, 2020
    Inventors: Robert Bradshaw, Rafael de Jesús Fernández Moctezuma, Daniel Mills, Samuel Green McVeety, Samuel Carl Whittle, Andrei Maksimenka, Cosmin Ionel Arad, Mark Brian Shields, Harris Samuel Nover, Manuel Alfred Fahndrich, Jeffrey Paul Gardner, Mikhail Shmulyan, Reuven Lax, Ahmet Altay, Craig D. Chambers
  • Patent number: 10695557
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: June 30, 2020
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Publication number: 20200179680
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Application
    Filed: December 3, 2019
    Publication date: June 11, 2020
    Inventors: David Townley, Brian Shields
  • Publication number: 20200179042
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Application
    Filed: December 3, 2019
    Publication date: June 11, 2020
    Inventors: David Townley, Brian Shields
  • Publication number: 20200179040
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Application
    Filed: December 3, 2019
    Publication date: June 11, 2020
    Inventors: David Townley, Brian Shields
  • Patent number: D1020689
    Type: Grant
    Filed: December 1, 2023
    Date of Patent: April 2, 2024
    Assignee: Pioneer Square Brands, Inc.
    Inventors: Emelie Elna Victoria Troedson, Kyle Shields, Brian Lewis Piper